Towards Healthcare
Osteoarthritis Therapeutics Market to Lead USD 24.52 Bn by 2034

Osteoarthritis Therapeutics Market Expanding with Biologics

Market insights predict, the osteoarthritis therapeutics industry is expected to grow from USD 9.95 billion in 2024 to USD 24.52 billion by 2034, driven by a CAGR of 9.45%. The rising prevalence of osteoarthritis is estimated to drive the growth of the market in the near future. North America led the global market owing to the high prevalence of osteoarthritis in the region.

Content

  • Insight Code: 6231
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: September 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Kesiya Chacko is an accomplished market research professional with over 4+ years of experience in the healthcare industry, known for delivering actionable insights and strategic analysis that empower healthcare organizations to navigate complex, rapidly evolving markets.

Kesiya began her research career with Precedence Research, where she built a strong foundation in pharmaceutical and healthcare market analysis. Today, she plays an integral role at Towards Healthcare, contributing to in-depth, client-centric research initiatives. She also brings her expertise to Statifacts, supporting broader research functions with a focus on cross-sector healthcare trends and data interpretation.

Her commitment to high-quality analysis, combined with a strong grasp of regulatory and market dynamics, makes her a trusted contributor to healthcare firms seeking future-ready, data-backed decisions. Kesiya’s work spans the analysis of industry trends, competitive benchmarking, and evaluation of regulatory and innovation-driven shifts.

Talk to us
FAQ's

The osteoarthritis therapeutics market is valued at USD 10.89 billion in 2025 and is on track to reach USD 24.52 billion by 2034, witnessing a steady CAGR of 9.45% during the forecast span.

North America is leading the osteoarthritis therapeutics market share by 41% due to the rising prevalence of osteoarthritis, advancements in osteoarthritis treatments, and the presence of major key players.

The osteoarthritis therapeutics market includes five segments including by drug class, by route of administration, by joint type, by distribution channel, and by region.

Key trends include the advanced injectable formulations & viscosupplementation, focus on research and development, and adoption of inorganic growth strategies.

Osteoarthritis Research Society International (OARSI), Personalized Medicine Coalition, SOAR - Society for Osteoarthritis Research, Government of Canada, OAFI Foundation: International Osteoarthritis Foundation, Food and Drug Administration, Arthritis Foundation, clinicaltrials.gov, American College of Rheumatology, GOV.UK and OARSI-Osteoarthritis Research Society International among others.
Any Questions